Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Colorectal Neoplasms

Free Subscription Articles published in Cancer Lett Retrieve available abstracts of 96 articles: HTML format

Single Articles

March 2026
1. HEROUX D, Sun XX, Zhang S, Sharifiaghdam M, et al
   Copper ionophores drive divergent responses to immune checkpoint inhibition across colorectal tumor models.
   Cancer Lett. 2026;641:218281.
   PubMed     Abstract available
   
   
   
2. CHEN Y, Liang J, Wu S, Zou Y, et al
   Traditional Chinese medicine and formulations for the treatment of colorectal cancer: Preclinical studies based on the concept of strengthening the body and eliminating pathogens.
   Cancer Lett. 2026;645:218390.
   PubMed     Abstract available
   
   
   
3. LING T, Zhang W, Cai H, Kien TT, et al
   TGM2-mediated serotonylation in tumor endothelial cells promotes angiogenesis and tumor growth in colorectal cancer.
   Cancer Lett. 2026 Mar 2:218396. doi: 10.1016/j.canlet.2026.218396.
   PubMed     Abstract available
   
   
   February 2026
4. FANG X, Huang H, Zhao Z, Yang L, et al
   KLF7 as a biomarker for the pre-metastatic state promotes colorectal cancer liver metastasis via TGFbeta autocrine signaling.
   Cancer Lett. 2026;639:218123.
   PubMed     Abstract available
   
   
   
5. MUOLLO MC, Biagini L, De Bellis D, Carnevali F, et al
   Letter to the editor on "Dietary intake of the red meat-derived glycan Neu5Gc fuels colorectal cancer through up-regulation of Wnt signaling pathway".
   Cancer Lett. 2026;643:218317.
   PubMed    
   
   
   January 2026
6. CHEN Z, Liang Z, Cai T, Yang X, et al
   ANGPTL3 promotes colorectal carcinoma progression and metastasis through regulating COL1A2 transcription via interacting with integrin alphaVbeta3.
   Cancer Lett. 2026;638:218150.
   PubMed     Abstract available
   
   
   
7. FENG S, Huang Q, Deng J, Jia W, et al
   Corrigendum to "DAB2IP suppresses tumor malignancy by inhibiting GRP75-driven p53 ubiquitination in colon cancer" [Cancer Lett. 532 (2022) 215588].
   Cancer Lett. 2026 Jan 14:218251. doi: 10.1016/j.canlet.2026.218251.
   PubMed    
   
   
   
8. LIU C, Nie J, Li S, Ma S, et al
   Electroacupuncture Combined with Fruquintinib and Sintilimab in Microsatellite-Stable Metastatic Colorectal Cancer: A Phase II Study.
   Cancer Lett. 2026 Jan 2:218238. doi: 10.1016/j.canlet.2026.218238.
   PubMed     Abstract available
   
   
   
9. TANG W, Lv Y, Xie H, Wei Y, et al
   Efficacy and safety of SHR-1701 combined with chemoradiotherapy as neoadjuvant treatment for locally advanced rectal cancer.
   Cancer Lett. 2026;636:218006.
   PubMed     Abstract available
   
   
   December 2025
10. FRANK M, Ghirardello G, Howie JM, Braun N, et al
    Spatial organization of stromal subtypes stratifies colorectal cancer patients and predicts clinical outcomes.
    Cancer Lett. 2025;639:218228.
    PubMed     Abstract available
    
    
    
11. LOU S, Wang H, Mo G, Li H, et al
    A TRIM21-UCHL3-ITCH-SIPA1 axis promotes colorectal cancer growth and metastasis.
    Cancer Lett. 2025 Dec 16:218221. doi: 10.1016/j.canlet.2025.218221.
    PubMed     Abstract available
    
    
    November 2025
12. ERMINE K, Chen D, Hao S, Liu Z, et al
    Reactivating necroptosis in colorectal cancer potentiates chemotherapy and antitumor immune responses.
    Cancer Lett. 2025 Nov 26:218169. doi: 10.1016/j.canlet.2025.218169.
    PubMed     Abstract available
    
    
    
13. TAN S, Chen Y, Chen Y, Liu S, et al
    HOXC8-activated TRIM22/NF-kappaB Pathway Promotes Stemness in Colorectal Cancer.
    Cancer Lett. 2025 Nov 18:218156. doi: 10.1016/j.canlet.2025.218156.
    PubMed     Abstract available
    
    
    
14. TSAI YY, Chang HY, Hong WZ, Chen JY, et al
    Targeting DRP1 promotes radiotherapy-induced antitumor immunity via mitochondrial DNA-mediated cGAS-STING signaling in KRAS-mutated colorectal cancer.
    Cancer Lett. 2025;637:218132.
    PubMed     Abstract available
    
    
    
15. PUZANOV GA, Astier C, Papakonstantinou D, Quiroga Londono M, et al
    Single-cell transcriptome profiling of post-treatment and treatment-naive colorectal cancer: Insights into putative mechanisms of chemoresistance.
    Cancer Lett. 2025;636:218127.
    PubMed     Abstract available
    
    
    
16. MA C, Awosika JA, Monge C, Coffman-D'Annibale K, et al
    Altering the gut microbiome and tumor microenvironment in advanced liver cancer: A phase II study of nivolumab, tadalafil and oral vancomycin in patients with refractory primary hepatocellular carcinoma or liver dominant metastatic cancer from colorec
    Cancer Lett. 2025;632:217975.
    PubMed     Abstract available
    
    
    October 2025
17. HAQUE PS, Paris SL, Souza RF, Onyiah JC, et al
    Obese adipose tissue-derived extracellular vesicles enriched with glycolytic cargo promote colorectal cancer tumorigenesis.
    Cancer Lett. 2025 Oct 28:218104. doi: 10.1016/j.canlet.2025.218104.
    PubMed     Abstract available
    
    
    
18. GUO Z, He L, Wang W, Tian S, et al
    Corrigendum to "FUT2-dependent fucosylation of LAMP1 promotes the apoptosis of colorectal cancer cells by regulating theautophagy-lysosomal pathway" [Cancer Lett. (2025) 619 217643].
    Cancer Lett. 2025 Oct 3:217981. doi: 10.1016/j.canlet.2025.217981.
    PubMed    
    
    
    September 2025
19. BAI F, Liao L, Tang Y, Wu Y, et al
    RCMIX model based on pre-treatment MRI imaging predicts T-downstage in MRI-cT4 stage rectal cancer.
    Cancer Lett. 2025;628:217871.
    PubMed     Abstract available
    
    
    
20. SUN L, Gao X, Wang M, Zhang Y, et al
    Gobal crotonylome reveals that HNRNPC and its crotonylation promote p53-deficient tumor growth by stabilizing CCND1 and MCM3 mRNAs.
    Cancer Lett. 2025;628:217854.
    PubMed     Abstract available
    
    
    
21. BAI M, Li N, Yin X, Huang C, et al
    An anti-PD-1 antibody (SCT-I10A) plus anti-EGFR antibody (SCT200) and chemotherapy for RAS/BRAF wild-type metastatic colorectal cancer: A phase Ib study.
    Cancer Lett. 2025 Sep 24:218061. doi: 10.1016/j.canlet.2025.218061.
    PubMed     Abstract available
    
    
    
22. YIN Z, Zhou Y, Zhu X, Goettl RA, et al
    Cancer-associated fibroblast secreted DKK1 promotes the immunosuppressive tumor microenvironment and colorectal cancer resistance to chemotherapy.
    Cancer Lett. 2025 Sep 24:218060. doi: 10.1016/j.canlet.2025.218060.
    PubMed     Abstract available
    
    
    August 2025
23. HORN DM, Phillips KA, Schulman KA
    Comparison of Food and Drug Administration Expedited Approvals and Guideline Updates: A Case Study of Immune Checkpoint Inhibitors in Colon Cancer Care.
    Cancer Lett. 2025 Aug 12:217979. doi: 10.1016/j.canlet.2025.217979.
    PubMed    
    
    
    
24. SUN Z, Wu R, Liang X, Shi T, et al
    MLCK inhibition induces synthetic lethality in MYC-driven cancer.
    Cancer Lett. 2025;625:217803.
    PubMed     Abstract available
    
    
    
25. TSAI HY, Chen MH, Yun J, Lai LA, et al
    Restricting metabolic plasticity enhances stress adaptation through the modulation of PDH and HIF1A in TRAP1-depleted colon cancer.
    Cancer Lett. 2025 Aug 9:217977. doi: 10.1016/j.canlet.2025.217977.
    PubMed     Abstract available
    
    
    
26. ZOU H, Liu Y, Yang X, Zhang Q, et al
    PRMT2 promotes tumorigenic phenotypes through the Wnt signaling pathway and drives immune suppression in Colorectal cancer.
    Cancer Lett. 2025 Aug 4:217967. doi: 10.1016/j.canlet.2025.217967.
    PubMed     Abstract available
    
    
    July 2025
27. MORGAN R, Bayat Tork MA, Lin Z, Wild C, et al
    High-Fat Diet Driven Post-Operative Colon Cancer Recurrence is Dependent upon Genetic Susceptibility to Deoxycholic Acid.
    Cancer Lett. 2025 Jul 22:217943. doi: 10.1016/j.canlet.2025.217943.
    PubMed     Abstract available
    
    
    
28. HAN S, Chen Z, Hong C, Dang T, et al
    Inhibition of KAT6A Enhances Immunotherapy Efficacy in Colorectal Cancer by Activating Interferon Response.
    Cancer Lett. 2025 Jul 22:217946. doi: 10.1016/j.canlet.2025.217946.
    PubMed     Abstract available
    
    
    
29. WANG H, Du S, Ji S, Miao G, et al
    SMARCA1-NPFF axis inhibits colorectal cancer metastasis by blocking epithelial-mesenchymal transition and macrophage-dependent immune reprogramming.
    Cancer Lett. 2025;631:217933.
    PubMed     Abstract available
    
    
    
30. HAN Y, Xu X, Peng Y, Zhu J, et al
    CircFLNB upregulated by chemotherapy via alternative splicing suppresses the progression of colorectal cancer.
    Cancer Lett. 2025;631:217932.
    PubMed     Abstract available
    
    
    
31. HE J, Li W, Wang S, Lan J, et al
    Cancer associated fibroblasts-derived lactate induces oxaliplatin treatment resistance by promoting cancer stemness via ANTXR1 lactylation in colorectal cancer.
    Cancer Lett. 2025;631:217917.
    PubMed     Abstract available
    
    
    
32. BIRGERSSON M, Holm M, Gallardo-Dodd CJ, Chen B, et al
    Intestinal estrogen receptor beta modulates the murine colon tumor immune microenvironment.
    Cancer Lett. 2025;622:217661.
    PubMed     Abstract available
    
    
    
33. DANEK V, Tureckova J, Huebner K, Erlenbach-Wuensch K, et al
    CUL4A exhibits tumor-suppressing role via regulation of HUWE1-mediated SMAD3 intracellular shuttling.
    Cancer Lett. 2025;621:217663.
    PubMed     Abstract available
    
    
    June 2025
34. GERAKOPOULOS V, Ramos C, Muller C, Walterskirchen N, et al
    Single-cell transcriptomic analysis identifies tissue-specific fibroblasts as the main modulators of myeloid cells in peritoneal metastasis of different origin.
    Cancer Lett. 2025;620:217678.
    PubMed     Abstract available
    
    
    
35. KHAN S, Karmokar A, Howells L, Britton RG, et al
    An old spice with new tricks: Curcumin targets adenoma and colorectal cancer stem-like cells associated with poor survival outcomes.
    Cancer Lett. 2025 Jun 19:217885. doi: 10.1016/j.canlet.2025.217885.
    PubMed     Abstract available
    
    
    
36. YU C, Lu W, Wu J, Fang X, et al
    Liver metastasis or peritoneal metastasis: single-cell RNA sequencing reveals the organotropism in colorectal cancer is driven by distinct partial-EMT processes.
    Cancer Lett. 2025 Jun 17:217880. doi: 10.1016/j.canlet.2025.217880.
    PubMed     Abstract available
    
    
    May 2025
37. MIDDE A, Arri N, Kristian T, Mukherjee S, et al
    Corrigendum to "Targeting mitochondrial ribosomal protein expression by andrographolide and melatonin for colon cancer treatment" [Cancer Lett. 619 (2025) 1-11 217647].
    Cancer Lett. 2025 May 30:217784. doi: 10.1016/j.canlet.2025.217784.
    PubMed    
    
    
    
38. ZHOU M, Guan B, Liu Y, Gu Q, et al
    Fibrinogen-like 2 in tumor-associated macrophage-derived extracellular vesicles shapes an immunosuppressive microenvironment in colorectal liver metastases by promoting tumor stemness and neutrophil extracellular traps formation.
    Cancer Lett. 2025;618:217642.
    PubMed     Abstract available
    
    
    
39. SUN Y, Lu J, Tung Lau EY, Zeng Y, et al
    Fusobacterium nucleatum enhances cholesterol biosynthesis in colorectal cancer via miR-130a-3p-mediated AMPK inhibition, a process counteracted by butyrate.
    Cancer Lett. 2025 May 23:217810. doi: 10.1016/j.canlet.2025.217810.
    PubMed     Abstract available
    
    
    
40. CHEN X, Cao Y, Zhao Y, Ma Y, et al
    Neurodegeneration of local sympathetic inputs promotes colorectal cancer progression.
    Cancer Lett. 2025;625:217817.
    PubMed     Abstract available
    
    
    
41. HU D, Zhao J, Wu M, Zhou Y, et al
    Microbial Interactions Induce the Mutational Signature of Mismatch Repair Deficiency in Colorectal Cancer and Associated with EPPK1 Mutations.
    Cancer Lett. 2025 May 16:217807. doi: 10.1016/j.canlet.2025.217807.
    PubMed     Abstract available
    
    
    
42. HE K, Wang H, Wu H, Li W, et al
    Activated Schwann cells promote tumor growth in colon cancer.
    Cancer Lett. 2025;626:217791.
    PubMed     Abstract available
    
    
    
43. LU YX, Ju HQ, Wang F, Chen LZ, et al
    Corrigendum to "Inhibition of the NF-kappaB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis" [Cancer Lett. 380 (2016) 87-97].
    Cancer Lett. 2025;625:217756.
    PubMed    
    
    
    
44. STRIPPOLI R
    Colorectal cancer peritoneal metastasis is promoted by tissue-specific fibroblasts that can arise in response to various local disorders.
    Cancer Lett. 2025;625:217749.
    PubMed    
    
    
    
45. ZHOU XY, Zhang NC, Zhang XN, Sun XD, et al
    The carcinogenic metabolite acetaldehyde impairs cGAS activity to negatively regulate antiviral and antitumor immunity.
    Cancer Lett. 2025;617:217615.
    PubMed     Abstract available
    
    
    April 2025
46. ZHONG YX, Zhao HB, Lian MH, Shen JM, et al
    SUMOylated hnRNPM suppresses PFKFB3 phosphorylation to regulate glycolysis and tumorigenesis.
    Cancer Lett. 2025;616:217573.
    PubMed     Abstract available
    
    
    
47. RAMOS C, Walterskirchen N, Knobl V, Zotter C, et al
    Colorectal cancer peritoneal metastasis is promoted by tissue-specific fibroblasts that can arise in response to various local disorders.
    Cancer Lett. 2025 Apr 12:217686. doi: 10.1016/j.canlet.2025.217686.
    PubMed     Abstract available
    
    
    
48. HOLDFELDT A, Salerno S, Stahlberg A, Lindskog EB, et al
    The colorectal cancer microenvironment governs clinical behaviors and chemotherapy response.
    Cancer Lett. 2025 Apr 1:217687. doi: 10.1016/j.canlet.2025.217687.
    PubMed    
    
    
    March 2025
49. RICHIARDONE E, Giolito MV, Al Roumi R, Ambroise J, et al
    Acidosis overrides molecular heterogeneity to shape therapeutically targetable metabolic phenotypes in colon cancers.
    Cancer Lett. 2025;613:217512.
    PubMed     Abstract available
    
    
    
50. GU Y, Ye Q, Huang X, Cao Y, et al
    Glycosaminoglycan modification of NRP1 exon 4-skipping variant drives colorectal cancer metastasis via endosomal-exosomal trafficking.
    Cancer Lett. 2025 Mar 27:217683. doi: 10.1016/j.canlet.2025.217683.
    PubMed     Abstract available
    
    
    
51. MIDDE A, Arri N, Kristian T, Mukherjee S, et al
    Targeting mitochondrial ribosomal protein expression by andrographolide and melatonin for colon cancer treatment.
    Cancer Lett. 2025;619:217647.
    PubMed     Abstract available
    
    
    
52. LI M, Gao X, Lin X, Zhang Y, et al
    Analysis of germline-somatic mutational connections in colorectal cancer reveals differential tumorigenic patterns and a novel predictive marker for germline mutation carriers.
    Cancer Lett. 2025 Mar 19:217637. doi: 10.1016/j.canlet.2025.217637.
    PubMed     Abstract available
    
    
    
53. GUO Z, He L, Wang W, Tian S, et al
    FUT2-dependent fucosylation of LAMP1 promotes the apoptosis of colorectal cancer cells by regulating the autophagy-lysosomal pathway.
    Cancer Lett. 2025 Mar 18:217643. doi: 10.1016/j.canlet.2025.217643.
    PubMed     Abstract available
    
    
    
54. YAO L, Yin H, Yang C, Han S, et al
    GENERATING RESEARCH HYPOTHESES TO OVERCOME KEY CHALLENGES IN THE EARLY DIAGNOSIS OF COLORECTAL CANCER - FUTURE APPLICATION OF AI.
    Cancer Lett. 2025 Mar 15:217632. doi: 10.1016/j.canlet.2025.217632.
    PubMed     Abstract available
    
    
    February 2025
55. LOPES AL, Paulino AC, Thaumaturgo MAS, Araujo WM, et al
    Dietary intake of the red meat-derived glycan Neu5Gc fuels colorectal cancer through up-regulation of Wnt signaling pathway.
    Cancer Lett. 2025;616:217598.
    PubMed     Abstract available
    
    
    
56. BAI M, Jin Y, Jin Z, Xie Y, et al
    Distinct Immunophenotypic Profiles and Neutrophil Heterogeneity in Colorectal Cancer.
    Cancer Lett. 2025 Feb 22:217570. doi: 10.1016/j.canlet.2025.217570.
    PubMed     Abstract available
    
    
    
57. WANG T, Weng M, Li K, Li G, et al
    LIN28B enhances the chemosensitivity of colon cancer cells via inducing genomic instability by upsetting the balance between the production and removal of reactive oxygen species.
    Cancer Lett. 2025 Feb 20:217572. doi: 10.1016/j.canlet.2025.217572.
    PubMed     Abstract available
    
    
    
58. ZHUO FF, Li L, Liu TT, Liang XM, et al
    Corrigendum to "Lycorine promotes IDH1 acetylation to induce mitochondrial dynamics imbalance in colorectal cancer cells" [Canc. Lett. 573 (2023) 216364].
    Cancer Lett. 2025 Feb 9:217533. doi: 10.1016/j.canlet.2025.217533.
    PubMed    
    
    
    January 2025
59. BAI X, Liu B, Fan D, Lu Y, et al
    Modulating the gut microbiota: A novel perspective in colorectal cancer treatment.
    Cancer Lett. 2025 Jan 11:217459. doi: 10.1016/j.canlet.2025.217459.
    PubMed     Abstract available
    
    
    
60. ZHAN Y, Sun D, Gao J, Gao Q, et al
    Single-cell Transcriptomics Reveals Intratumor Heterogeneity and the Potential Roles of Cancer Stem Cells and myCAFs in Colorectal Cancer Liver Metastasis and Recurrence.
    Cancer Lett. 2025 Jan 11:217452. doi: 10.1016/j.canlet.2025.217452.
    PubMed     Abstract available
    
    
    December 2024
61. XU C, Jiang C, Tian Y, Liu Y, et al
    Nervous system in colorectal cancer.
    Cancer Lett. 2024 Dec 24:217431. doi: 10.1016/j.canlet.2024.217431.
    PubMed     Abstract available
    
    
    
62. ZHOU Y, Lei T, Tang Z, Guo P, et al
    Increased phosphorylation of AMPKalpha1 S485 in colorectal cancer and identification of PKCalpha as a responsible kinase.
    Cancer Lett. 2024 Dec 24:217418. doi: 10.1016/j.canlet.2024.217418.
    PubMed     Abstract available
    
    
    
63. MALIER M, Laverriere MH, Henry M, Yakoubi M, et al
    Tumor-associated macrophages confer resistance to chemotherapy (Trifluridine/Tipiracil) in digestive cancers by overexpressing thymidine phosphorylase.
    Cancer Lett. 2024;606:217307.
    PubMed     Abstract available
    
    
    November 2024
64. DONG Z, Ojha A, Barlow L, Luo L, et al
    The eIF3a translational control axis in the Wnt/beta-catenin signaling pathway and colon tumorigenesis.
    Cancer Lett. 2024;605:217303.
    PubMed     Abstract available
    
    
    
65. O'BRIEN RM, Meltzer S, Buckley CE, Heeran AB, et al
    Complement is increased in treatment resistant rectal cancer and modulates radioresistance.
    Cancer Lett. 2024;604:217253.
    PubMed     Abstract available
    
    
    
66. YAO B, Wu J
    Letter to the editor on 'A deep neural network predictor to predict the sensitivity of neoadjuvant chemoradiotherapy in locally advanced rectal cancer'.
    Cancer Lett. 2024;604:217212.
    PubMed    
    
    
    September 2024
67. TAN YT, Li T, Wang RB, Liu ZK, et al
    WTAP weakens oxaliplatin chemosensitivity of colorectal cancer by preventing PANoptosis.
    Cancer Lett. 2024;604:217254.
    PubMed     Abstract available
    
    
    
68. YANG H, Gong C, Wu Y, Xie X, et al
    LncRNA SNHG1 facilitates colorectal cancer cells metastasis by recruiting HNRNPD protein to stabilize SERPINA3 mRNA.
    Cancer Lett. 2024 Sep 2:217217. doi: 10.1016/j.canlet.2024.217217.
    PubMed     Abstract available
    
    
    August 2024
69. LI M, Xie Y, Zhang J, Zhou X, et al
    Intratumoral injection of mRNA encoding survivin in combination with STAT3 inhibitor stattic enhances antitumor effects.
    Cancer Lett. 2024;598:217111.
    PubMed     Abstract available
    
    
    
70. ZHOU L, Wen R, Bai C, Li Z, et al
    Spatial transcriptomic revealed intratumor heterogeneity and cancer stem cell enrichment in colorectal cancer metastasis.
    Cancer Lett. 2024 Aug 17:217181. doi: 10.1016/j.canlet.2024.217181.
    PubMed     Abstract available
    
    
    
71. HAN Y, Pu Y, Liu X, Liu Z, et al
    YTHDF1 regulates GID8-mediated glutamine metabolism to promote colorectal cancer progression in a m6A-dependent manner.
    Cancer Lett. 2024 Aug 14:217186. doi: 10.1016/j.canlet.2024.217186.
    PubMed     Abstract available
    
    
    
72. LING T, Dai Z, Wang H, Kien TT, et al
    Serotonylation in tumor-associated fibroblasts contributes to the tumor-promoting roles of serotonin in colorectal cancer.
    Cancer Lett. 2024 Aug 1:217150. doi: 10.1016/j.canlet.2024.217150.
    PubMed     Abstract available
    
    
    July 2024
73. KONG WS, Li JJ, Deng YQ, Ju HQ, et al
    Immunomodulatory molecules in colorectal cancer liver metastasis.
    Cancer Lett. 2024;598:217113.
    PubMed     Abstract available
    
    
    
74. ZHU N, Ding Y, Mi M, Yang J, et al
    Loss-of-function mutation of REV1 (p.R704Q) mediates cetuximab primary resistance by activating autophagy in RAS-wild type metastatic colorectal cancer.
    Cancer Lett. 2024 Jul 3:217103. doi: 10.1016/j.canlet.2024.217103.
    PubMed     Abstract available
    
    
    
75. LUO XJ, Lu YX, Wang Y, Huang R, et al
    M6A-modified lncRNA FAM83H-AS1 promotes colorectal cancer progression through PTBP1.
    Cancer Lett. 2024 Jul 2:217085. doi: 10.1016/j.canlet.2024.217085.
    PubMed     Abstract available
    
    
    
76. RICHIARDONE E, Al Roumi R, Lardinois F, Giolito MV, et al
    MCT1-dependent lactate recycling is a metabolic vulnerability in colorectal cancer cells upon acquired resistance to anti-EGFR targeted therapy.
    Cancer Lett. 2024 Jul 2:217091. doi: 10.1016/j.canlet.2024.217091.
    PubMed     Abstract available
    
    
    
77. CHEN Q, Chen J, Deng Y, Bi X, et al
    Personalized prediction of postoperative complication and survival among Colorectal Liver Metastases Patients Receiving Simultaneous Resection using machine learning approaches: A multi-center study.
    Cancer Lett. 2024;593:216967.
    PubMed     Abstract available
    
    
    
78. HUANG C, Tan H, Wang J, Huang L, et al
    beta-hydroxybutyrate restrains colitis-associated tumorigenesis by inhibiting HIF-1alpha-mediated angiogenesis.
    Cancer Lett. 2024;593:216940.
    PubMed     Abstract available
    
    
    June 2024
79. HANG D, Sun D, Du L, Huang J, et al
    Development and evaluation of a risk prediction tool for risk-adapted screening of colorectal cancer in China.
    Cancer Lett. 2024;597:217057.
    PubMed     Abstract available
    
    
    
80. YUAN M, Zhang C, Chen S, Ye S, et al
    PDP1 promotes KRAS mutant colorectal cancer progression by serving as a scaffold for BRAF and MEK1.
    Cancer Lett. 2024;597:217007.
    PubMed     Abstract available
    
    
    
81. BIAN Y, Xu S, Gao Z, Ding J, et al
    m(6)A modification of lncRNA ABHD11-AS1 promotes colorectal cancer progression and inhibits ferroptosis through TRIM21/IGF2BP2/ FOXM1 positive feedback loop.
    Cancer Lett. 2024 Jun 3:217004. doi: 10.1016/j.canlet.2024.217004.
    PubMed     Abstract available
    
    
    May 2024
82. AGORKU DJ, Bosio A, Alves F, Strobel P, et al
    Colorectal cancer-associated fibroblasts inhibit effector T cells via NECTIN2 signaling.
    Cancer Lett. 2024;595:216985.
    PubMed     Abstract available
    
    
    
83. LUN J, Zhang Y, Yu M, Zhai W, et al
    Circular RNA circHIPK2 inhibits colon cancer cells through miR-373-3p/RGMA axis.
    Cancer Lett. 2024;593:216957.
    PubMed     Abstract available
    
    
    
84. LIU Y, Shi J, Liu W, Tang Y, et al
    A deep neural network predictor to predict the sensitivity of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Cancer Lett. 2024;589:216641.
    PubMed     Abstract available
    
    
    April 2024
85. YANG Y, Qi J, Hu J, Zhou Y, et al
    Lovastatin/SN38 co-loaded liposomes amplified ICB therapeutic effect via remodeling the immunologically-cold colon tumor and synergized stimulation of cGAS-STING pathway.
    Cancer Lett. 2024;588:216765.
    PubMed     Abstract available
    
    
    
86. JIN Y, Jiang J, Mao W, Bai M, et al
    Treatment strategies and molecular mechanism of radiotherapy combined with immunotherapy in colorectal cancer.
    Cancer Lett. 2024;591:216858.
    PubMed     Abstract available
    
    
    
87. ZHOU X, Zhang K, Wang C, Teng Y, et al
    Isthmin-1 promotes growth and progression of colorectal cancer through the interaction with EGFR and YBX-1.
    Cancer Lett. 2024 Apr 7:216868. doi: 10.1016/j.canlet.2024.216868.
    PubMed     Abstract available
    
    
    
88. JIANG C, Zhou Q, Yi K, Yuan Y, et al
    Colorectal cancer initiation: Understanding early-stage disease for intervention.
    Cancer Lett. 2024 Apr 2:216831. doi: 10.1016/j.canlet.2024.216831.
    PubMed     Abstract available
    
    
    March 2024
89. ZHOU Y, Li H, Zhang Y, Zhao E, et al
    Deubiquitinase USP4 suppresses antitumor immunity by inhibiting IRF3 activation and tumor cell-intrinsic interferon response in colorectal cancer.
    Cancer Lett. 2024 Mar 29:216836. doi: 10.1016/j.canlet.2024.216836.
    PubMed     Abstract available
    
    
    
90. LIN J, Zhong W, Lyu Z, Peng J, et al
    Circular RNA circTATDN3 promotes the Warburg effect and proliferation in colorectal cancer.
    Cancer Lett. 2024 Mar 26:216825. doi: 10.1016/j.canlet.2024.216825.
    PubMed     Abstract available
    
    
    
91. ZHANG D, Xie J, Sun F, Xu R, et al
    Pharmacological suppression of HHLA2 glycosylation restores anti-tumor immunity in colorectal cancer.
    Cancer Lett. 2024 Mar 22:216819. doi: 10.1016/j.canlet.2024.216819.
    PubMed     Abstract available
    
    
    
92. HISANO K, Mizuuchi Y, Ohuchida K, Kawata J, et al
    Microenvironmental changes in familial adenomatous polyposis during colorectal cancer carcinogenesis.
    Cancer Lett. 2024;589:216822.
    PubMed     Abstract available
    
    
    
93. ZHU Z, Li M, Weng J, Li S, et al
    LncRNA GAS6-AS1 contributes to 5-fluorouracil resistance in colorectal cancer by facilitating the binding of PCBP1 with MCM3.
    Cancer Lett. 2024 Mar 21:216828. doi: 10.1016/j.canlet.2024.216828.
    PubMed     Abstract available
    
    
    
94. TANG Y, Wei J, Ge X, Yu C, et al
    Intratumoral injection of interferon gamma promotes the efficacy anti-PD1 treatment in colorectal cancer.
    Cancer Lett. 2024 Mar 9:216798. doi: 10.1016/j.canlet.2024.216798.
    PubMed     Abstract available
    
    
    
95. CHEN Q, Deng Y, Li Y, Chen J, et al
    Association of preoperative aspartate aminotransferase to platelet ratio index with outcomes and tumour microenvironment among colorectal cancer with liver metastases.
    Cancer Lett. 2024 Mar 6:216778. doi: 10.1016/j.canlet.2024.216778.
    PubMed     Abstract available
    
    
    January 2024
96. LIU C, Cheng X, Han K, Hong L, et al
    A novel molecular subtyping based on multi-omics analysis for prognosis predicting in colorectal melanoma: A 16-year prospective multicentric study.
    Cancer Lett. 2024 Jan 19:216663. doi: 10.1016/j.canlet.2024.216663.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum